ATI LPN
PN ATI Capstone Pharmacology 1 Quiz
1. A nurse is caring for a patient whose family member requests to view the patient’s medical record. What response should the nurse make?
- A. “The patient should provide permission to share the records with you.â€
- B. “You can view the records if the provider approves it.â€
- C. “I will allow you to see the chart if the patient is unable to give consent.â€
- D. “You need to fill out a request form.â€
Correct answer: A
Rationale: In this scenario, the nurse should respond by indicating that the patient needs to provide permission to share their medical records with the family member. Patient confidentiality is a fundamental principle in healthcare, and sharing medical records without the patient's consent is a violation of privacy. Choice B is incorrect because the provider's approval alone is not sufficient to share medical records, as patient consent is crucial. Choice C is incorrect because viewing the patient's chart without the patient's consent is not appropriate. Choice D is incorrect as filling out a request form does not address the issue of patient consent, which is essential for sharing medical information.
2. A nurse is reviewing the laboratory results for a client who has end-stage liver disease. Which of the following findings should the nurse expect?
- A. Elevated albumin
- B. Elevated ammonia
- C. Decreased total bilirubin
- D. Decreased prothrombin time
Correct answer: B
Rationale: In end-stage liver disease, the liver's inability to convert ammonia into urea leads to elevated ammonia levels. Elevated ammonia levels can result in hepatic encephalopathy, a serious complication. Therefore, the correct answer is B. Elevated albumin (Choice A) is not typically seen in end-stage liver disease as liver dysfunction often leads to decreased albumin levels. Decreased total bilirubin (Choice C) is unlikely in end-stage liver disease, as bilirubin levels tend to be elevated due to impaired liver function. Decreased prothrombin time (Choice D) is also not expected in end-stage liver disease, as impaired liver function results in prolonged prothrombin time.
3. A client who signed an informed consent form for surgery but has since expressed doubts about the need for surgery is being assisted by a nurse. Which of the following statements should the nurse make?
- A. You should not worry about it
- B. The surgeon will answer your questions before surgery
- C. It’s too late to cancel the surgery
- D. You need to trust the medical team
Correct answer: B
Rationale: The correct answer is B because the nurse should encourage the client to express concerns and ensure that the surgeon addresses any questions prior to the procedure. Choice A is incorrect as it dismisses the client's worries. Choice C is incorrect because it does not respect the client's autonomy in decision-making. Choice D is incorrect as it does not address the client's doubts directly or provide reassurance.
4. A nurse is assessing a client who has Parkinson's disease. Which of the following manifestations should the nurse expect?
- A. Pruritus
- B. Hypertension
- C. Bradykinesia
- D. Xerostomia
Correct answer: C
Rationale: The correct answer is C: Bradykinesia. Bradykinesia, which refers to slowness of movement, is a characteristic symptom of Parkinson's disease. Other common manifestations in Parkinson's disease include tremors, muscle rigidity, orthostatic hypotension, and drooling. Pruritus (choice A) is unrelated to Parkinson's disease. While hypertension (choice B) can coexist with Parkinson's disease due to autonomic dysfunction, it is not a specific hallmark manifestation. Xerostomia (choice D) is not a primary symptom associated with Parkinson's disease.
5. A healthcare provider is providing education on the use of atorvastatin. Which of the following should be included?
- A. Monitor for liver function
- B. It can cause muscle pain
- C. It is safe to take during pregnancy
- D. Both A and B
Correct answer: D
Rationale: Atorvastatin requires monitoring for liver function due to its potential to cause liver abnormalities. It can also lead to muscle pain or weakness, a condition known as myopathy. Choice C is incorrect as atorvastatin is contraindicated during pregnancy due to potential harm to the fetus, making choices A and B the correct options to include in patient education.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access